About Synedgen

Board of Directors

Board of Directors

Dr. Shenda Baker is President, Chief Operating Officer, Treasurer and Co-founder of Synedgen. She has more than 20 years of experience conducting, generating funds for, and directing chemistry, materials science, and biochemistry research. She provides scientific leadership, manages the intellectual property as well as the scientific and regulatory collaborations, and provides financial and organizational oversight at Synedgen. Previously, Dr. Baker was a professor of Chemistry at Harvey Mudd College from 1991-2014. She served on the Board of Directors of the Materials Research Society and has served on advisory boards with the National Institutes of Health, National Science Foundation and the Department of Energy. She is co-inventor on all of the Synedgen technology.

Robert Coughlin is President and CEO of the Massachusetts Biotechnology Council, (MassBio). Prior to his position at MassBio he served as the Undersecretary of Economic Development within Governor Deval Patrick’s administration and as State Representative to the 11th Norfolk district. He has held senior executive positions in the environmental services industry, capital management and venture capital. He is a past board member of the Massachusetts Maritime Academy and Beth Israel Deaconess Hospital, and currently serving on the board of directors for The Schwartz Center for Compassionate Healthcare and Aridis Pharmaceuticals. He also is a member of the Scientific Advisory Board at Boston Children’s Hospital and an active participant in fundraising and raising awareness of cystic fibrosis.

Dr. Kenton Gregory is executive director of the Oregon Medical Laser Center at Providence St. Vincent in Portland, Oregon. He is a practicing interventional cardiologist and recipient of the first endowed chair in laser medicine and surgery. He is the founder and President of Oregon Biomedical Engineering Institute, an R&D company, and Biomedical Research Services, a scientific and technical consulting company. Dr. Gregory serves as an associate professor of biomedical engineering at the Oregon Graduate Institute of Science and Technology and an assistant professor of medicine at Oregon Health and Science University. He has been Principal Investigator on 5 FDA sponsored clinical trials and received over $30 million in grants to research novel techniques for the repair and replacement of tissues.

Dr. Paul Grint is Chief Executive Officer at Regulus Therapeutics, where he was formerly Chief Medical Officer. Previously, as President of Cerexa, Dr. Grint was responsible for the oversight of anti-infective product development. He has held many executive positions leading research and development at Forest Research Institute, Kalypsys, Zephyr Sciences, Pfizer, IDEC Pharmaceuticals, Schering-Plough, and Biogen Idec. Dr. Grint is a Director of Numira Biosciences, and also serves as a member of Scientific Advisory Boards at MultiCell Technologies, Tobira Therapeutics, and CovX Research.

Andrew Miller is the President and CEO of Stimson Lumber Company in Portland, Oregon. Stimson is an integrated timberland and wood products manufacturing company with operations in the northwestern U.S. Prior to joining Stimson in 1991, Mr. Miller was employed in the Forest Products Industry with Plum Creek Timber and Weyerhaeuser. Mr. Miller serves on multiple regional and national industry association Boards, and several non-profit Boards in the Portland area.

Dr. Larry Shapiro is the Spencer T. and Ann W. Olin Distinguished Professor and Executive Vice Chancellor and Dean of the School of Medicine at Washington University in St. Louis. His research interests include human molecular genetics and inborn errors of metabolism. Previously, he was W.H. and Marie Wattis Distinguished Professor and Chairman of the Department of Pediatrics at University of California, San Francisco; and Chief of Pediatric Services at the UCSF Children’s Hospital. Dr. Shapiro was also Professor of Pediatrics and Biological Chemistry at the UCLA School of Medicine and an Investigator in the Howard Hughes Medical Institute. Dr. Shapiro is an elected member of the Institute of Medicine of the National Academies and the American Academy of Arts and Sciences. He is also a Fellow of the American Academy of Pediatrics, and the American Association for the Advancement of  Science, and is a past president of the American Pediatric Society, the Society for Pediatric Research, and the American Society of Human Genetics.

Dr. William Wiesmann is Chief Executive Officer, Chairman of the Board, and Co-founder of Synedgen. He is an accomplished inventor and entrepreneur. Backed by millions in research funding, Dr. Wiesmann has founded multiple biotech companies, including Hawaii Chitopure, BioSTAR West, HemCon Medical Technologies and Tissue Genesis. Dr. Wiesmann served as the Director for Combat Casualty Care at the U.S. Army Medical Research and Material Command Post, at Ft. Detrick, until he retired from the Army as a colonel in 1997. His innovations have transformed medicine both on the battlefield and in civilian trauma centers. In 2004, the military named his 4-by-4-inch HemCon bandage one of the year’s “Top 10 Greatest Inventions” for its ability to stop seriously wounded soldiers from bleeding to death. He also holds 34 awarded or pending patents from his work in biosensors, automated diagnostic devices, and advanced tissue engineering.